- Report
- August 2021
- 1800 Pages
Global
From €2426EUR$2,550USD£2,065GBP
€2854EUR$3,000USD£2,429GBP
- Report
- June 2020
- 150 Pages
Global
From €2668EUR$2,805USD£2,271GBP
€3139EUR$3,300USD£2,672GBP
- Clinical Trials
- July 2019
- 170 Pages
Global
From €2426EUR$2,550USD£2,065GBP
€2854EUR$3,000USD£2,429GBP
- Report
- April 2019
- 1200 Pages
Global
From €2264EUR$2,380USD£1,927GBP
€2664EUR$2,800USD£2,267GBP
- Report
- April 2018
- 120 Pages
Global
From €1941EUR$2,040USD£1,652GBP
€2283EUR$2,400USD£1,943GBP
- Report
- May 2018
- 305 Pages
Global
From €3948EUR$4,150USD£3,361GBP
- Report
- March 2023
- 180 Pages
Global
From €5660EUR$5,950USD£4,818GBP
- Report
- December 2022
- 100 Pages
Global
From €5660EUR$5,950USD£4,818GBP
- Report
- October 2022
- 150 Pages
Global
From €5660EUR$5,950USD£4,818GBP
- Report
- June 2021
- 135 Pages
Asia Pacific
From €5660EUR$5,950USD£4,818GBP
- Report
- January 2023
- 127 Pages
Global
From €2377EUR$2,499USD£2,024GBP
- Report
- April 2023
- 150 Pages
Global
From €4614EUR$4,850USD£3,927GBP
- Report
- July 2022
- 100 Pages
Global
From €2616EUR$2,750USD£2,227GBP
- Report
- August 2018
- 15 Pages
Global
- Report
- July 2018
- 15 Pages
Global
- Report
- August 2022
- 115 Pages
Global
From €4519EUR$4,750USD£3,846GBP
- Report
- August 2022
- 104 Pages
Global
From €4519EUR$4,750USD£3,846GBP
- Report
- July 2022
- 140 Pages
Global
From €4519EUR$4,750USD£3,846GBP
- Report
- November 2023
- 120 Pages
From €1998EUR$2,100USD£1,701GBP
€2854EUR$3,000USD£2,429GBP
- Report
- February 2023
- 206 Pages
Global
From €3030EUR$3,185USD£2,579GBP
€4329EUR$4,550USD£3,685GBP
The Mesenchymal Stem Cell (MSC) market is a rapidly growing sector of the genomics industry. MSCs are multipotent cells that can differentiate into a variety of cell types, including bone, cartilage, and fat. They are used in regenerative medicine, tissue engineering, and drug discovery. MSCs are also being studied for their potential to treat a variety of diseases, including cancer, autoimmune disorders, and cardiovascular diseases.
The MSC market is driven by advances in genomics technology, such as gene editing and sequencing, which have enabled researchers to better understand the biology of MSCs and develop new therapeutic applications. Additionally, the increasing demand for personalized medicine and the growing awareness of the potential of MSCs to treat a variety of diseases are driving the growth of the MSC market.
Some of the major companies in the MSC market include Thermo Fisher Scientific, Merck KGaA, Lonza Group, STEMCELL Technologies, and Cellular Dynamics International. Show Less Read more